SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: Number 99.1 Major Operating Data of the First
[Number 99.1 Major Operating Data of the First Quarter of 2019. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Shi Wei]
VIPS [Vipshop] 6-K: (Original Filing)
[001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 Peoples Republic of China Form 20-F x o o o Appointment of New Chief Technology Officer 2 Vipshop Holdings Limited]
VIPS [Vipshop] 6-K: 001-35454 Vipshop Holdings Limited No. 20 Huahai Street
[001-35454 Vipshop Holdings Limited No. 20 Huahai Street Liwan District, Guangzhou 510370 Peoples Republic of China Form 20-F x o o o Appointment of New Chief Technology Officer 2 Vipshop Holdings Limited]
CHL [CHINA MOBILE] 6-K: (Original Filing)
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[China Eastern Airlines Corporation Limited Date April 15, 2019 By Wang Jian Company Secretary]
CHL [CHINA MOBILE] 6-K: Number 1.1 Notice of the Annual General Meeting,
[Number 1.1 Notice of the Annual General Meeting, dated April 12, 2019 2.1 Circular, dated April 12, 2019 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansio]
CEA [CHINA EASTERN AIRLINES] 6-K: China Eastern Airlines Corporation Limited Date April 15,
[China Eastern Airlines Corporation Limited Date April 15, 2019 By Wang Jian Company Secretary]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Update on the Exchange of Rights for
[Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares April 12, 2019 05:04 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an updat]
SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: (Original Filing)
[Number 99.1 Major Operating Data of the First Quarter of 2019. SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Shi Wei]
